Literature DB >> 21074826

Coincident idiopathic focal segmental glomerulosclerosis collapsing variant and diabetic nephropathy in an African American homozygous for MYH9 risk variants.

Isai Gopalakrishnan1, Samy S Iskandar, Pirouz Daeihagh, Jasmin Divers, Carl D Langefeld, Donald W Bowden, Pamela J Hicks, Michael V Rocco, Barry I Freedman.   

Abstract

Familial clustering of disparate kidney diseases including clinically diagnosed hypertensive and diabetic nephropathy, idiopathic focal segmental glomerulosclerosis, and HIV-associated nephropathy are often observed in African Americans. Admixture mapping recently identified the nonmuscle myosin heavy chain 9 gene (MYH9) as a susceptibility factor strongly associated with several nondiabetic etiologies of end-stage renal disease in African Americans, less strongly with diabetes-associated end-stage renal disease. MYH9-associated nephropathies reside in the spectrum of focal segmental glomerulosclerosis/focal global glomerulosclerosis. The renal histology in proteinuric African Americans homozygous for MYH9 risk variants with longstanding type 2 diabetes mellitus is unknown. We report a case of coincident idiopathic focal segmental glomerulosclerosis collapsing variant and diabetic nephropathy in an African American homozygous for the MYH9 E1 risk haplotype. This case demonstrates that diabetic African Americans with overt proteinuria can have mixed renal lesions, including those in the spectrum of MYH9-associated nephropathy. Careful interpretation of kidney biopsies in proteinuric African Americans with diabetes is necessary to exclude coincident nondiabetic forms of nephropathy, precisely define etiologies of kidney disease, and determine the natural history and treatment response in mixed lesions of diabetes-associated and MYH9-associated kidney disease. Copyright Â
© 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21074826      PMCID: PMC3022108          DOI: 10.1016/j.humpath.2010.07.016

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  14 in total

1.  Pathologic classification of focal segmental glomerulosclerosis: a working proposal.

Authors:  Vivette D D'Agati; Agnes B Fogo; Jan A Bruijn; J Charles Jennette
Journal:  Am J Kidney Dis       Date:  2004-02       Impact factor: 8.860

2.  MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis.

Authors:  Jeffrey B Kopp; Michael W Smith; George W Nelson; Randall C Johnson; Barry I Freedman; Donald W Bowden; Taras Oleksyk; Louise M McKenzie; Hiroshi Kajiyama; Tejinder S Ahuja; Jeffrey S Berns; William Briggs; Monique E Cho; Richard A Dart; Paul L Kimmel; Stephen M Korbet; Donna M Michel; Michele H Mokrzycki; Jeffrey R Schelling; Eric Simon; Howard Trachtman; David Vlahov; Cheryl A Winkler
Journal:  Nat Genet       Date:  2008-09-14       Impact factor: 38.330

Review 3.  The spectrum of MYH9-associated nephropathy.

Authors:  Meredith A Bostrom; Barry I Freedman
Journal:  Clin J Am Soc Nephrol       Date:  2010-03-18       Impact factor: 8.237

Review 4.  Glomerular involvement in type II diabetes - is it all diabetic glomerulosclerosis?

Authors:  D Cordonnier
Journal:  Nephrol Dial Transplant       Date:  1996-06       Impact factor: 5.992

5.  Prevalence of non-diabetic renal disease among African-American patients with type II diabetes mellitus.

Authors:  C M Nzerue; K Hewan-Lowe; P Harvey; D Mohammed; B Furlong; R Oster
Journal:  Scand J Urol Nephrol       Date:  2000-10

6.  Glomerular lesions in HIV-positive patients: a 20-year biopsy experience from Northern Italy.

Authors:  M Nebuloni; G Barbiano di Belgiojoso; A Genderini; A Tosoni; N L; M Heidempergher; P Zerbi; L Vago
Journal:  Clin Nephrol       Date:  2009-07       Impact factor: 0.975

7.  An evaluation of renal biopsy in type-II diabetic patients.

Authors:  Muhammad Arif; Muhammad Khubaib Arif; Muhammad Sohaib Arif
Journal:  J Coll Physicians Surg Pak       Date:  2009-10       Impact factor: 0.711

Review 8.  Genetic factors in diabetic nephropathy.

Authors:  Barry I Freedman; Meredith Bostrom; Pirouz Daeihagh; Donald W Bowden
Journal:  Clin J Am Soc Nephrol       Date:  2007-10-17       Impact factor: 8.237

9.  The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group.

Authors:  E J Lewis; L G Hunsicker; R P Bain; R D Rohde
Journal:  N Engl J Med       Date:  1993-11-11       Impact factor: 91.245

Review 10.  The link between hypertension and nephrosclerosis.

Authors:  B I Freedman; S S Iskandar; R G Appel
Journal:  Am J Kidney Dis       Date:  1995-02       Impact factor: 8.860

View more
  14 in total

Review 1.  Renal disease in HIV-infected individuals.

Authors:  John Phair; Frank Palella
Journal:  Curr Opin HIV AIDS       Date:  2011-07       Impact factor: 4.283

2.  The new era of APOL1-associated glomerulosclerosis.

Authors:  Barry I Freedman; Carl D Langefeld
Journal:  Nephrol Dial Transplant       Date:  2012-02-02       Impact factor: 5.992

Review 3.  Target organ damage in African American hypertension: role of APOL1.

Authors:  Barry I Freedman; Mariana Murea
Journal:  Curr Hypertens Rep       Date:  2012-02       Impact factor: 5.369

4.  Collapsing focal segmental glomerulosclerosis: Current concepts.

Authors:  Muhammed Mubarak
Journal:  World J Nephrol       Date:  2012-04-06

Review 5.  Diabetic Microvascular Disease: An Endocrine Society Scientific Statement.

Authors:  Eugene J Barrett; Zhenqi Liu; Mogher Khamaisi; George L King; Ronald Klein; Barbara E K Klein; Timothy M Hughes; Suzanne Craft; Barry I Freedman; Donald W Bowden; Aaron I Vinik; Carolina M Casellini
Journal:  J Clin Endocrinol Metab       Date:  2017-12-01       Impact factor: 5.958

6.  Polymorphisms in MYH9 are associated with diabetic nephropathy in European Americans.

Authors:  Jessica N Cooke; Meredith A Bostrom; Pamela J Hicks; Maggie C Y Ng; Jacklyn N Hellwege; Mary E Comeau; Jasmin Divers; Carl D Langefeld; Barry I Freedman; Donald W Bowden
Journal:  Nephrol Dial Transplant       Date:  2011-10-03       Impact factor: 5.992

Review 7.  Gene-gene and gene-environment interactions in apolipoprotein L1 gene-associated nephropathy.

Authors:  Barry I Freedman; Karl Skorecki
Journal:  Clin J Am Soc Nephrol       Date:  2014-06-05       Impact factor: 8.237

8.  Center-Level Experience and Kidney Transplant Outcomes in HIV-Infected Recipients.

Authors:  J E Locke; R D Reed; S G Mehta; C Durand; R B Mannon; P MacLennan; B Shelton; M Y Martin; H Qu; R Shewchuk; D L Segev
Journal:  Am J Transplant       Date:  2015-03-13       Impact factor: 8.086

9.  Complement factor H gene associations with end-stage kidney disease in African Americans.

Authors:  Jason A Bonomo; Nicholette D Palmer; Pamela J Hicks; Janice P Lea; Mark D Okusa; Carl D Langefeld; Donald W Bowden; Barry I Freedman
Journal:  Nephrol Dial Transplant       Date:  2014-02-28       Impact factor: 5.992

Review 10.  Population ancestry and genetic risk for diabetes and kidney, cardiovascular, and bone disease: modifiable environmental factors may produce the cures.

Authors:  Barry I Freedman; Jasmin Divers; Nicholette D Palmer
Journal:  Am J Kidney Dis       Date:  2013-07-26       Impact factor: 8.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.